Literature DB >> 31369087

Mechanisms of antimicrobial-induced nephrotoxicity in children.

Kevin J Downes1,2,3,4, Molly Hayes5, Julie C Fitzgerald6,7, Gwendolyn M Pais8,9, Jiajun Liu8,9,10, Nicole R Zane3, Stuart L Goldstein11,12, Marc H Scheetz8,9,10,13, Athena F Zuppa3,6,7.   

Abstract

Drug-induced nephrotoxicity is responsible for 20% to 60% of cases of acute kidney injury in hospitalized patients and is associated with increased morbidity and mortality in both children and adults. Antimicrobials are one of the most common classes of medications prescribed globally and also among the most common causes of nephrotoxicity. A broad range of antimicrobial agents have been associated with nephrotoxicity, but the features of kidney injury vary based on the agent, its mechanism of injury and the site of toxicity within the kidney. Distinguishing nephrotoxicity caused by an antimicrobial agent from other potential inciting factors is important to facilitate both early recognition of drug toxicity and prompt cessation of an offending drug, as well as to avoid unnecessary discontinuation of an innocuous therapy. This review will detail the different types of antimicrobial-induced nephrotoxicity: acute tubular necrosis, acute interstitial nephritis and obstructive nephropathy. It will also describe the mechanism of injury caused by specific antimicrobial agents and classes (vancomycin, aminoglycosides, polymyxins, antivirals, amphotericin B), highlight the toxicodynamics of these drugs and provide guidance on administration or monitoring practices that can mitigate toxicity, when known. Particular attention will be paid to paediatric patients, when applicable, in whom nephrotoxin exposure is an often-underappreciated cause of kidney injury.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31369087      PMCID: PMC6910165          DOI: 10.1093/jac/dkz325

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  146 in total

1.  Safety and efficacy of intravenous colistin in children.

Authors:  Poddutoor Preetham Kumar; Swapnil Rameshwar Giri; Farhan A R Shaikh; Nalinikant Panigrahy; Dinesh Chirla
Journal:  Indian Pediatr       Date:  2015-02       Impact factor: 1.411

Review 2.  Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.

Authors:  Laiza M Steimbach; Fernanda S Tonin; Suzane Virtuoso; Helena H L Borba; Andréia C C Sanches; Astrid Wiens; Fernando Fernandez-Llimós; Roberto Pontarolo
Journal:  Mycoses       Date:  2016-11-22       Impact factor: 4.377

Review 3.  New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view.

Authors:  Jose M Lopez-Novoa; Yaremi Quiros; Laura Vicente; Ana I Morales; Francisco J Lopez-Hernandez
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 4.  Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.

Authors:  R A Branch
Journal:  Arch Intern Med       Date:  1988-11

5.  Intravenous acyclovir and renal dysfunction in children: a matched case control study.

Authors:  Suchitra Rao; Mark J Abzug; Phyllis Carosone-Link; Tori Peterson; Jason Child; Georgette Siparksy; Danielle Soranno; Melissa A Cadnapaphornchai; Eric A F Simões
Journal:  J Pediatr       Date:  2015-02-21       Impact factor: 4.406

6.  The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.

Authors:  Ann Versporten; Julia Bielicki; Nico Drapier; Mike Sharland; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2016-01-08       Impact factor: 5.790

7.  Ciprofloxacin crystal nephropathy.

Authors:  Piero Stratta; Elisa Lazzarich; Caterina Canavese; Cristina Bozzola; Guido Monga
Journal:  Am J Kidney Dis       Date:  2007-08       Impact factor: 8.860

Review 8.  Renal toxicity of therapeutic drugs.

Authors:  R John; A M Herzenberg
Journal:  J Clin Pathol       Date:  2009-06       Impact factor: 3.411

9.  The use of colistin in critically ill children in a pediatric intensive care unit.

Authors:  Adem Karbuz; Halil Özdemir; Ayhan Yaman; Bilge Aldemir Kocabaş; Çağlar Odek; Haluk Güriz; Ahmet Derya Aysev; Ergin Çiftçi; Tanil Kendirli; Can Ateş; Erdal İnce
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

10.  Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.

Authors:  Blanca Humanes; Juan Carlos Jado; Sonia Camaño; Virginia López-Parra; Ana María Torres; Luís Antonio Álvarez-Sala; Emilia Cercenado; Alberto Tejedor; Alberto Lázaro
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

View more
  8 in total

1.  Factors associated with acyclovir nephrotoxicity in children: data from 472 pediatric patients from the last 10 years.

Authors:  Rumeysa Yalçınkaya; Fatma Nur Öz; Ayşe Kaman; Türkan Aydın Teke; Sevgi Yaşar Durmuş; Evra Çelikkaya; Gönül Tanır
Journal:  Eur J Pediatr       Date:  2021-05-06       Impact factor: 3.183

2.  Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.

Authors:  Ahmed A Mahmoud; Sean N Avedissian; Abbas Al-Qamari; Tiffany Bohling; Michelle Pham; Marc H Scheetz
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447

3.  Polymyxin Acute Kidney Injury: a case of severe tubulopathy.

Authors:  Lucas Alexandre de Mello Goldin; Leticia Nicoletti Silva; Thiago Florencio da Silva; Vinicius Daher Alvares Delfino
Journal:  J Bras Nefrol       Date:  2022 Jan-Mar

Review 4.  Kidney disease in children with heart or liver transplant.

Authors:  Amrit Kirpalani; Chia Wei Teoh; Vicky Lee Ng; Anne I Dipchand; Mina Matsuda-Abedini
Journal:  Pediatr Nephrol       Date:  2021-02-18       Impact factor: 3.714

5.  Too Much of a Good Thing: Defining Antimicrobial Therapeutic Targets to Minimize Toxicity.

Authors:  Kevin J Downes; Jennifer L Goldman
Journal:  Clin Pharmacol Ther       Date:  2021-02-27       Impact factor: 6.875

Review 6.  Microsampling Assays for Pharmacokinetic Analysis and Therapeutic Drug Monitoring of Antimicrobial Drugs in Children: A Critical Review.

Authors:  Ganesh S Moorthy; Christina Vedar; Kevin J Downes; Julie C Fitzgerald; Marc H Scheetz; Athena F Zuppa
Journal:  Ther Drug Monit       Date:  2021-06-01       Impact factor: 3.118

Review 7.  Polyene Antibiotics Physical Chemistry and Their Effect on Lipid Membranes; Impacting Biological Processes and Medical Applications.

Authors:  Tammy Haro-Reyes; Lucero Díaz-Peralta; Arturo Galván-Hernández; Anahi Rodríguez-López; Lourdes Rodríguez-Fragoso; Iván Ortega-Blake
Journal:  Membranes (Basel)       Date:  2022-06-30

8.  Drug-induced kidney injury in Chinese critically ill pediatric patients.

Authors:  Biwen Hu; Ling Ye; Tong Li; Zeying Feng; Longjian Huang; Chengjun Guo; Li He; Wei Tan; Guoping Yang; Zhiling Li; Chengxian Guo
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.